Amnesty calls out Cellebrite DI (CLBT) for spy tech misuse in Serbia
Cellebrite DI has come under pressure after an allegation that its tech was used for unethical practices in Serbia. The company’s phone unlocking technology was used to install home-grown spyware on the mobile devices of journalists and activists.
Serbia used Israeli firm’s tech to enable spy campaign, Amnesty says
Serbian officials installed homegrown spyware on the phones of dozens of journalists and activists, Amnesty International said in a report released on Monday, citing digital forensic evidence and testimony from activists who said they were hacked in recent months.
Amnesty accuses Serbia of spying on journalists and activists
By bne IntelliNews Amnesty International has accused Serbian authorities of conducting covert surveillance on journalists, activists and civil society members through advanced spyware and digital forensic tools,
Serbian police used spyware to keep track of opponents and journalists, Amnesty says
Serbia’s secret service and police have been spying on journalists and opposition activists by installing a spyware on their mobile phones, Amnesty International said Monday.
Serbia has been illegally spying on political opponents and journalists, Amnesty says
Amnesty International says Serbia’s secret service and police have been spying on journalists and opposition activists by installing a spyware on their mobile phones. The report published Monday is backed by testimonies of those who claim their phones have been hacked in recent months.
Business Insider12h
Cellebrite DI: Strategic Focus on Inseyets Platform and Complementary Applications Drive Buy Rating with Over 20% Upside Potential
William Blair analyst Jonathan Ho has maintained their bullish stance on CLBT stock, giving a Buy rating today. Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks! Easily ...
news.stocktradersdaily3d
(CLBT) On The My Stocks Page
Check the time stamp on this data. Updated AI-Generated Signals for Cellebrite Di Ltd. (CLBT) available here: CLBT.
Analysts Set Cellebrite DI Ltd. (NASDAQ:CLBT) PT at $20.29
Shares of Cellebrite DI Ltd. (NASDAQ:CLBT – Get Free Report) have received an average recommendation of “Buy” from the eight research firms that are currently covering the company, Marketbeat.com ...
Cellebrite price target raised to $24 from $22 at JPMorgan
JPMorgan raised the firm’s price target on Cellebrite (CLBT) to $24 from $22 and keeps an Overweight rating on the shares. The firm updating ...
Yahoo Finance23d
CLBT Dec 2024 22.500 call (CLBT241220C00022500)
There are no important events for this country at this time. Select "All" to see top events in other countries or view all events.
28,386 Shares in Cellebrite DI Ltd. (NASDAQ:CLBT) Purchased by Healthcare of Ontario Pension Plan Trust Fund
Healthcare of Ontario Pension Plan Trust Fund bought a new position in Cellebrite DI Ltd. (NASDAQ:CLBT – Free Report) in the ...